BlueCrest Capital Management’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-4,300
Closed -$230K 230
2023
Q1
$230K Buy
+4,300
New +$249K 0.01% 241
2018
Q3
Sell
-29,050
Closed -$1.53M 1573
2018
Q2
$1.53M Buy
+29,050
New +$1.57M 0.04% 394
2017
Q3
Sell
-151,022
Closed -$10.2M 909
2017
Q2
$10.2M Buy
+151,022
New +$10.3M 0.4% 46
2016
Q4
Sell
-129,655
Closed -$7.01M 720
2016
Q3
$7.01M Buy
+129,655
New +$6.53M 0.22% 104
2015
Q3
Sell
-2,840
Closed -$226K 905
2015
Q2
$226K Buy
+2,840
New +$241K 0.01% 755

Other funds holding ENOV

BlueCrest Capital Management's ENOV Position: Q2 2023 in Review

BlueCrest Capital Management sold out of Enovis (ENOV) in Q2 2023, closing a stake of 4,300 shares — an estimated $230K sold.

BlueCrest Capital Management first reported a position in ENOV in Q2 2015 and held it in 5 quarters. The position peaked at $10.2M in Q2 2017. 261 funds tracked by Wall St. Rank hold ENOV as of Q2 2023.

  • BlueCrest Capital Management reported no remaining Enovis position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 4,300 Enovis shares in Q2 2023, an estimated $230K.
  • BlueCrest Capital Management first reported a position in Enovis in Q2 2015 and held it in 5 quarters.
  • BlueCrest Capital Management's Enovis position peaked at $10.2M in Q2 2017.
  • 261 funds tracked by Wall St. Rank held Enovis as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.